Drug · DIN 02238096
TARKA
No: no longer authorized
The company stopped selling it and its DIN was cancelled. A cancellation is most often a business decision; the record does not say why.
Status Cancelled Post Market since November 12, 2010; first marketed July 15, 2002.
- Drug Identification Number (DIN)
- 02238096
- Company (DIN owner)
- Abbott Laboratories Co.Saint-Laurent, Quebec, Canada
- Schedule
- Prescription
- Dosage form
- Tablet (Extended-Release)
- Route
- Oral
- Therapeutic class (ATC)
- Trandolapril and verapamil C09BB10
- Class
- Human
- Record last updated
- March 22, 2025
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| TRANDOLAPRIL | 2 MG | |
| VERAPAMIL HYDROCHLORIDE | 180 MG |
Notices of Compliance
Health Canada approvals that name this DIN.
- June 22, 2001: NOC 2638New Drug Submission (NDS) · Change in manufacturer's name
- June 5, 1998: NOC 3237New Drug Submission (NDS)
Other DINs named TARKA
- DIN 02238097 · Cancelled Post Market
- DIN 02240945 · Cancelled Post Market
- DIN 02240946 · Cancelled Post Market